Dragonfly

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing therapies by leveraging its novel bispecific antibody technology to harness the human body's innate immune system, bringing breakthrough treatments to patients. Dragonfly has a robust pipeline of wholly-owned preclinical candidates discovered through its proprietary platform, which are advancing toward clinical development. The company has also established productive collaborations with Merck, AbbVie, Gilead, and Bristol-Myers Squibb across a wide range of disease areas.